DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $273,768,000 | +37.6% | 2,073,685 | +7.5% | 0.19% | +22.8% |
| Q4 2018 | $198,989,000 | -49.4% | 1,929,684 | -46.7% | 0.16% | +23.4% |
| Q3 2018 | $393,314,000 | +107.7% | 3,619,680 | +88.6% | 0.13% | +0.8% |
| Q2 2018 | $189,349,000 | -3.5% | 1,918,818 | -4.2% | 0.13% | -4.5% |
| Q1 2018 | $196,206,000 | +7.0% | 2,003,946 | +1.4% | 0.13% | +9.9% |
| Q4 2017 | $183,431,000 | +12.5% | 1,976,203 | +3.9% | 0.12% | +9.0% |
| Q3 2017 | $163,100,000 | -6.6% | 1,901,371 | -8.1% | 0.11% | -9.8% |
| Q2 2017 | $174,563,000 | -23.0% | 2,068,523 | -21.9% | 0.12% | -24.5% |
| Q1 2017 | $226,575,000 | +4.0% | 2,649,076 | -5.3% | 0.16% | +0.6% |
| Q4 2016 | $217,813,000 | +5.1% | 2,798,212 | +5.8% | 0.16% | +24.6% |
| Q3 2016 | $207,288,000 | -21.1% | 2,644,313 | +1.7% | 0.13% | -35.3% |
| Q2 2016 | $262,610,000 | +2.5% | 2,600,098 | -3.7% | 0.20% | +2.6% |
| Q1 2016 | $256,240,000 | +20.5% | 2,701,241 | +17.9% | 0.20% | +23.3% |
| Q4 2015 | $212,733,000 | +9.5% | 2,290,404 | +0.5% | 0.16% | +4.6% |
| Q3 2015 | $194,232,000 | -13.5% | 2,279,448 | -13.1% | 0.15% | -4.4% |
| Q2 2015 | $224,461,000 | -9.3% | 2,622,510 | -10.0% | 0.16% | -7.6% |
| Q1 2015 | $247,427,000 | -14.7% | 2,914,330 | -13.9% | 0.17% | -15.3% |
| Q4 2014 | $290,159,000 | -4.4% | 3,385,357 | -15.3% | 0.20% | -6.0% |
| Q3 2014 | $303,568,000 | -0.7% | 3,995,363 | +2.9% | 0.22% | +1.4% |
| Q2 2014 | $305,676,000 | -6.4% | 3,882,585 | -10.8% | 0.21% | -9.4% |
| Q1 2014 | $326,511,000 | +1.1% | 4,353,478 | +4.1% | 0.24% | +1.3% |
| Q4 2013 | $322,844,000 | +28.0% | 4,181,918 | +14.9% | 0.23% | +17.8% |
| Q3 2013 | $252,248,000 | +3.6% | 3,638,889 | -5.4% | 0.20% | -0.5% |
| Q2 2013 | $243,529,000 | – | 3,847,217 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |